Methylglyoxal couples metabolic and translational control of Notch signalling in mammalian neural stem cells.

Gene regulation and metabolism are two fundamental processes that coordinate the self-renewal and differentiation of neural precursor cells (NPCs) in the developing mammalian brain. However, little is known about how metabolic signals instruct gene expression to control NPC homeostasis. Here, we show that methylglyoxal, a glycolytic intermediate metabolite, modulates Notch signalling to regulate NPC fate decision. We find that increased methylglyoxal suppresses the translation of Notch1 receptor mRNA in mouse and human NPCs, which is mediated by binding of the glycolytic enzyme GAPDH to an AU-rich region within Notch1 3ʹUTR. Interestingly, methylglyoxal inhibits the enzymatic activity of GAPDH and engages it as an RNA-binding protein to suppress Notch1 translation. Reducing GAPDH levels or restoring Notch signalling rescues methylglyoxal-induced NPC depletion and premature differentiation in the developing mouse cortex. Taken together, our data indicates that methylglyoxal couples the metabolic and translational control of Notch signalling to control NPC homeostasis.


Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.

n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.

For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection Imaged were taken with a 20X objective on an Olympus IX81 fluorescence microscope equipped with a Hamamatsu C9100-13 backthinned EM-CCD camera and Okogawa CSU X1 spinning disk confocal scan head with Volocity software (Perkin Elmer, 6.0) or a FV3000 confocal microscope from Olympus. Images were processed using ImageJ v1.51w. Western blot images were acquired on a BioRad ChemiDoc MP system using ImageLab 5.2.1 software, or LI-COR Odysssey using Image Studio 5.2 software and analyzed using Empiria Studio 1.2 REMSA images were taken using GE Typhoon FLA9500 Phosphorimager and analyzed using ImageQuant TL 8.1 software

Data analysis
Confocal microscope images were processed using ImageJ v1.51w with the FIJI plugin. Western blot images were analyzed using either ImageLab 5.2.1 or Empiria Studio 1.2 softwares. FACS data was analyzed using BD FACSDiva 8.0.1 For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability The source data underlying Figures  Field-specific reporting Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.

Life sciences Behavioural & social sciences Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Sample size
No calculations were performed to predetermine sample-size. Sample sizes was determined to be adequate based on the magnitude and consistency of measurable differences between groups. >= 3 animals or experiments were used as indicated in the figure legends.
Data exclusions no data excluded.

Replication
The experiments were repeated for 3 times unless otherwise indicated in the raw data file. All attempts at replication were successful.
Randomization No randomization was used in this manuscript. The data reported in our experiments is not affected by sample allocation.

Blinding
The investigators were not blinded to experimental groups during data collection and analysis. Data reported for these experiments is not subjective.

Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. Mouse anti-βIII-tubulin 1:1000 https://www.biolegend.com/en-us/products/purified-anti-tubulin-beta-3-tubb3-antibody-11580

Flow Cytometry
Plots Confirm that: The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.

Methodology
Sample preparation EGFP+ cortices from embryos of each experimental group were dissected, pooled and dissociated into single-cell suspensions in ice-cold HBSS. Dissociated cells were filtered through a 40μm cell strainer to obtain suspended single cells. FACS was performed using a BD FACS Aria II cell sorter. The EGFP signal was detected at a 530/30nm bandpass using a 488nm laser, and dead cells were stained with propidium iodide and excluded. EGFP+ cells were sorted into ice-cold FBS, followed by the centrifugation for 5 minutes at 200xg at 4°C and total RNA analysis. Cell population abundance The total number of EGFP+ cells in post-sort fractions ranged from 11,000-51,000 cells per sample, with a purity of >83%.

Gating strategy
Gating strategy can be found in Data Source File.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.